Nuclear and degradative functions of the ESCRT-III pathway: implications for neurodegenerative disease

References

• Hatano T, Palani S, Papatziamou D, et al. Asgard archaea shed light on the evolutionary origins of the eukaryotic ubiquitin-ESCRT machinery. Nat Commun. 2022;13(1):3398. doi: 10.1038/s41467-022-30656-2
   PubMed Web of Science ®Google Scholar
• Hurley JH. The ESCRT complexes. Crit Rev Biochem Mol Biol. 2010;45(6):463–20. doi: 10.3109/10409238.2010.502516
   PubMed Web of Science ®Google Scholar
• Hurley JH. Escrts are everywhere. Embo J. 2015;34(19):2398–2407. doi: 10.15252/embj.201592484
   PubMed Web of Science ®Google Scholar
• McCullough J, Frost A, Sundquist WI. Structures, functions, and dynamics of ESCRT-III/Vps4 membrane remodeling and fission complexes. Annu Rev Cell Dev Biol. 2018;34(1):85–109. doi: 10.1146/annurev-cellbio-100616-060600
   PubMed Web of Science ®Google Scholar
• Olmos Y. The ESCRT machinery: remodeling, repairing, and sealing membranes. Membranes. 2022;12(6):633. doi: 10.3390/membranes12060633
   PubMed Web of Science ®Google Scholar
• Remec Pavlin M, Hurley JH. The ESCRTs - converging on mechanism. J Cell Sci. 2020;133(18). doi: 10.1242/jcs.240333
   PubMed Web of Science ®Google Scholar
• Schmidt O, Teis D. The ESCRT machinery. Curr Biol. 2012;22(4):R116–20. doi: 10.1016/j.cub.2012.01.028
   PubMed Web of Science ®Google Scholar
• Vietri M, Radulovic M, Stenmark H. The many functions of ESCRTs. Nat Rev Mol Cell Biol. 2019;21(1):25–42. doi: 10.1038/s41580-019-0177-4
   PubMed Web of Science ®Google Scholar
• Schöneberg J, Pavlin MR, Yan S, et al. ATP-dependent force generation and membrane scission by ESCRT-III and Vps4. Science. 2018;362(6421):1423–1428.
   PubMed Web of Science ®Google Scholar
• Krylova SV, Feng D. The machinery of exosomes: biogenesis, release, and uptake. Int J Mol Sci. 2023;24(2). doi: 10.3390/ijms24021337
   Web of Science ®Google Scholar
• Lusk CP, Ader NR. Chmpions of repair: emerging perspectives on sensing and repairing the nuclear envelope barrier. Curr Opin Cell Biol. 2020;64:25–33. doi: 10.1016/j.ceb.2020.01.011
   PubMed Web of Science ®Google Scholar
• Votteler J, Sundquist WI. Virus budding and the ESCRT pathway. Cell Host Microbe. 2013;14(3):232–241. doi: 10.1016/j.chom.2013.08.012
   PubMed Web of Science ®Google Scholar
• Wollert T, Hurley JH. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature. 2010;464(7290):864–869. doi: 10.1038/nature08849
   PubMed Web of Science ®Google Scholar
• Zhou F, Wu Z, Zhao M, et al. Rab5-dependent autophagosome closure by ESCRT. J Cell Bio. 2019;218(6):1908–1927. doi: 10.1083/jcb.201811173
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang M, Zhang Y-Y, et al. The endosomal sorting complex required for transport repairs the membrane to delay cell death. Front Oncol. 2022;12:1007446. doi: 10.3389/fonc.2022.1007446
   PubMed Web of Science ®Google Scholar
• Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126(Pt 24):5553–5565. doi: 10.1242/jcs.128868
   PubMed Web of Science ®Google Scholar
• Juan T, Fürthauer M. Biogenesis and function of ESCRT-dependent extracellular vesicles. Semin Cell Dev Biol. 2018;74:66–77. doi: 10.1016/j.semcdb.2017.08.022
   PubMed Web of Science ®Google Scholar
• Larios J, Mercier V, Roux A, et al. ALIX- and ESCRT-III–dependent sorting of tetraspanins to exosomes. Journal of Cell Biology. 2020;219(3): doi: 10.1083/jcb.201904113
   PubMed Web of Science ®Google Scholar
• Borah S, Dhanasekaran K, Kumar S. The LEM-ESCRT toolkit: repair and maintenance of the nucleus. Front Cell Dev Biol. 2022;10:989217. doi: 10.3389/fcell.2022.989217
   PubMed Web of Science ®Google Scholar
• Gatta AT, Carlton JG. The ESCRT-machinery: closing holes and expanding roles. Curr Opin Cell Biol. 2019;59:121–132. doi: 10.1016/j.ceb.2019.04.005
   PubMed Web of Science ®Google Scholar
• Isono E. ESCRT is a great Sealer: non-endosomal function of the ESCRT Machinery in Membrane Repair and autophagy. Plant Cell Physiol. 2021;62(5):766–774. doi: 10.1093/pcp/pcab045
   PubMed Web of Science ®Google Scholar
• Denais CM, Gilbert RM, Isermann P, et al. Nuclear envelope rupture and repair during cancer cell migration. Science. 2016;352(6283):353–358. doi: 10.1126/science.aad7297
   PubMed Web of Science ®Google Scholar
• Jimenez AJ, Maiuri P, Lafaurie-Janvore J, et al. ESCRT machinery is required for plasma membrane repair. Science. 2014;343(6174):1247136.
   PubMed Web of Science ®Google Scholar
• Loncle N, Agromayor M, Martin-Serrano J, et al. An ESCRT module is required for neuron pruning. Sci Rep. 2015;5(1):8461. doi: 10.1038/srep08461
   PubMedGoogle Scholar
• Olmos Y, Hodgson L, Mantell J, et al. ESCRT-III controls nuclear envelope reformation. Nature. 2015;522(7555):236–239. doi: 10.1038/nature14503
   PubMed Web of Science ®Google Scholar
• Raab M, Gentili M, de Belly H, et al. ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death. Science. 2016;352(6283):359–362.
   PubMed Web of Science ®Google Scholar
• Scheffer LL, Sreetama SC, Sharma N, et al. Mechanism of Ca2+-triggered ESCRT assembly and regulation of cell membrane repair. Nat Commun. 2014;5(1):5646. doi: 10.1038/ncomms6646
   PubMedGoogle Scholar
• Skowyra ML, Schlesinger PH, Naismith TV, et al. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science. 2018;360(6384). doi: 10.1126/science.aar5078
   PubMed Web of Science ®Google Scholar
• Vietri M, Schink KO, Campsteijn C, et al. Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing. Nature. 2015;522(7555):231–235. doi: 10.1038/nature14408
   PubMed Web of Science ®Google Scholar
• Webster BM, Colombi P, Jäger J, et al. Surveillance of nuclear pore complex assembly by ESCRT-III/Vps4. Cell. 2014;159(2):388–401. DOI:10.1016/j.cell.2014.09.012
   PubMed Web of Science ®Google Scholar
• Lee JA, Gao FB. Neuronal functions of ESCRTs. Exp Neurobiol. Exp Neurobiol. 2012;21(1):9–15. doi: 10.5607/en.2012.21.1.9
   PubMedGoogle Scholar
• Chandra S, Lusk CP. Emerging connections between nuclear pore complex homeostasis and ALS. Int J Mol Sci. 2022;23(3). doi: 10.3390/ijms23031329
   Web of Science ®Google Scholar
• Kaul Z, Chakrabarti O. Endosomal sorting complexes required for ESCRTing cells toward death during neurogenesis, neurodevelopment and neurodegeneration. Traffic. 2018;19(7):485–495. doi: 10.1111/tra.12569
   PubMed Web of Science ®Google Scholar
• Hu YB, Dammer EB, Ren R-J, et al. The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration. Transl Neurodegener. 2015;4(1):18. doi: 10.1186/s40035-015-0041-1
   PubMedGoogle Scholar
• Lee JA, Gao FB. ESCRT, autophagy, and frontotemporal dementia. BMB Rep. 2008;41(12):827–832. doi: 10.5483/BMBRep.2008.41.12.827
   PubMed Web of Science ®Google Scholar
• Lee JA, Gao FB. Roles of ESCRT in autophagy-associated neurodegeneration. Autophagy. 2008;4(2):230–232. doi: 10.4161/auto.5384
   PubMed Web of Science ®Google Scholar
• Raiborg C, Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature. 2009;458(7237):445–452. doi: 10.1038/nature07961
   PubMed Web of Science ®Google Scholar
• Rusten TE, Simonsen A. ESCRT functions in autophagy and associated disease. Cell Cycle. 2008;7(9):1166–1172. doi: 10.4161/cc.7.9.5784
   PubMed Web of Science ®Google Scholar
• Todd TW, Shao W, Zhang Y-J, et al. The endolysosomal pathway and ALS/FTD. Trends Neurosci. 2023;46(12):1025–1041. doi: 10.1016/j.tins.2023.09.004
   PubMed Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3(1):17071. doi: 10.1038/nrdp.2017.71
   PubMed Web of Science ®Google Scholar
• Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7(11):603–615. doi: 10.1038/nrneurol.2011.150
   PubMed Web of Science ®Google Scholar
• Ferrari R, Kapogiannis DD, Huey E, et al. FTD and ALS: a tale of two diseases. Curr Alzheimer Res. 2011;8(3):273–294. doi: 10.2174/156720511795563700
   PubMed Web of Science ®Google Scholar
• Geser F, Martinez-Lage M, Kwong LK, et al. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol. 2009;256(8):1205–1214. doi: 10.1007/s00415-009-5069-7
   PubMed Web of Science ®Google Scholar
• Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918–1929. doi: 10.1111/ene.14393
   PubMed Web of Science ®Google Scholar
• Wheaton MW, Salamone AR, Mosnik DM, et al. Cognitive impairment in familial ALS. Neurology. 2007;69(14):1411–1417. doi: 10.1212/01.wnl.0000277422.11236.2c
   PubMed Web of Science ®Google Scholar
• Antonioni A, Raho EM, Lopriore P, et al. Frontotemporal Dementia, where do we stand? A narrative review. IJMS. 2023;24(14):11732. doi: 10.3390/ijms241411732
   Google Scholar
• Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386(10004):1672–1682. doi: 10.1016/S0140-6736(15)00461-4
   PubMed Web of Science ®Google Scholar
• Boeve BF, Boxer AL, Kumfor F, et al. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 2022;21(3):258–272. doi: 10.1016/S1474-4422(21)00341-0
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Greene SR. The relationship between amyotrophic lateral sclerosis and frontotemporal dementia. Curr Neurol Neurosci Rep. 2006;6(5):387–392. doi: 10.1007/s11910-996-0019-6
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie I, Boeve B, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245–256. doi: 10.1016/j.neuron.2011.09.011
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–268. doi: 10.1016/j.neuron.2011.09.010
   PubMed Web of Science ®Google Scholar
• Clayton EL, Mizielinska S, Edgar JR, et al. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Acta Neuropathol. 2015;130(4):511–523. doi: 10.1007/s00401-015-1475-3
   PubMed Web of Science ®Google Scholar
• Cox LE, Ferraiuolo L, Goodall EF, et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLOS One. 2010;5(3):e9872.
   PubMed Web of Science ®Google Scholar
• Roos P. et al. CHMP2B frontotemporal dementia, in GeneReviews® M.P. Adam, et al., Editors. 1993, University of Washington, Seattle copyright © 1993-2020 GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved. Seattle: WA.
   Google Scholar
• Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005;37(8):806–808. doi: 10.1038/ng1609
   PubMed Web of Science ®Google Scholar
• van der Zee J, Urwin H, Engelborghs S, et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet. 2008;17(2):313–322. doi: 10.1093/hmg/ddm309
   PubMed Web of Science ®Google Scholar
• Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14(9):544–558. doi: 10.1038/s41582-018-0047-2
   PubMed Web of Science ®Google Scholar
• Ghasemi M, Brown RH Jr. Genetics of amyotrophic lateral sclerosis. Cold Spring Harb Perspect Med. 2018;8(5):a024125. doi: 10.1101/cshperspect.a024125
   PubMed Web of Science ®Google Scholar
• Greaves CV, Rohrer JD. An update on genetic frontotemporal dementia. J Neurol. 2019;266(8):2075–2086. doi: 10.1007/s00415-019-09363-4
   PubMed Web of Science ®Google Scholar
• Gregory JM, Fagegaltier D, Phatnani H, et al. Genetics of amyotrophic lateral sclerosis. Current Genet Med Rep. 2020;8(4):121–131. doi: 10.1007/s40142-020-00194-8
   Google Scholar
• Olszewska DA, Lonergan R, Fallon EM, et al. Genetics of frontotemporal dementia. Curr Neurol Neurosci Rep. 2016;16(12):107. doi: 10.1007/s11910-016-0707-9
   PubMed Web of Science ®Google Scholar
• Orr HT. FTD and ALS: genetic ties that bind. Neuron. 2011;72(2):189–190. doi: 10.1016/j.neuron.2011.10.001
   PubMed Web of Science ®Google Scholar
• Irwin KE, Jasin P, Braunstein KE, et al. Author correction: a fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD. Nat Med. 2024. doi: 10.1038/s41591-024-02966-z
   Web of Science ®Google Scholar
• Seddighi S, Qi YA, Brown AL, et al. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD. Sci Transl Med. 2024:eadg7162.
   Google Scholar
• Bodansky A, Kim JMH, Tempest L, et al. TDP-43 and ubiquitinated cytoplasmic aggregates in sporadic ALS are low frequency and widely distributed in the lower motor neuron columns independent of disease spread. Amyotroph Lateral Scler. 2010;11(3): 321–327. DOI:10.3109/17482961003602363
   PubMed Web of Science ®Google Scholar
• Brown AL, Wilkins OG, Keuss MJ, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603(7899):131–137. doi: 10.1038/s41586-022-04436-3
   PubMed Web of Science ®Google Scholar
• Cohen TJ, Lee VM, Trojanowski JQ. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med. 2011;17(11):659–667. doi: 10.1016/j.molmed.2011.06.004
   PubMed Web of Science ®Google Scholar
• de Boer EMJ, Orie VK, Williams T, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2020;92(1):86–95. doi: 10.1136/jnnp-2020-322983
   PubMed Web of Science ®Google Scholar
• Highley JR, Kirby J, Jansweijer JA, et al. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol Appl Neurobiol. 2014;40(6):670–685. doi: 10.1111/nan.12148
   PubMed Web of Science ®Google Scholar
• Klim JR, Williams LA, Limone F, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22(2):167–179. doi: 10.1038/s41593-018-0300-4
   PubMed Web of Science ®Google Scholar
• Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43. Cell. 2009;136(6):1001–1004. doi: 10.1016/j.cell.2009.03.006
   PubMed Web of Science ®Google Scholar
• Ling JP, Pletnikova O, Troncoso JC, et al. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349(6248):650–655. doi: 10.1126/science.aab0983
   PubMed Web of Science ®Google Scholar
• Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416–438. doi: 10.1016/j.neuron.2013.07.033
   PubMed Web of Science ®Google Scholar
• Neumann M. Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci. 2009;10(1):232–246. doi: 10.3390/ijms10010232
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–133. doi: 10.1126/science.1134108
   PubMed Web of Science ®Google Scholar
• Prudencio M, Humphrey J, Pickles S, et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J Clin Invest. 2020;130(11):6080–6092. doi: 10.1172/JCI139741
   PubMed Web of Science ®Google Scholar
• Suk TR, Rousseaux MWC. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener. 2020;15(1):45.
   PubMed Web of Science ®Google Scholar
• Barmada SJ. Linking RNA dysfunction and neurodegeneration in amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12(2):340–351. doi: 10.1007/s13311-015-0340-3
   PubMed Web of Science ®Google Scholar
• Boeynaems S, Bogaert E, Van Damme P, et al. Inside out: the role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol. 2016;132(2):159–173. doi: 10.1007/s00401-016-1586-5
   PubMed Web of Science ®Google Scholar
• Fiesel FC, Kahle PJ. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration. FEBS J. 2011;278(19):3550–3568. doi: 10.1111/j.1742-4658.2011.08258.x
   PubMed Web of Science ®Google Scholar
• Hutten S, Dormann D. Nucleocytoplasmic transport defects in neurodegeneration — cause or consequence? Semin Cell Dev Biol. 2019;99:151–162. doi: 10.1016/j.semcdb.2019.05.020
   PubMed Web of Science ®Google Scholar
• Janssens J, Van Broeckhoven C. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum Mol Genet. 2013;22(R1):R77–87. doi: 10.1093/hmg/ddt349
   PubMed Web of Science ®Google Scholar
• Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet. 2017;136(9):1193–1214. doi: 10.1007/s00439-017-1830-7
   PubMed Web of Science ®Google Scholar
• Kim HJ, Taylor JP. Lost in transportation: Nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases. Neuron. 2017;96(2):285–297. doi: 10.1016/j.neuron.2017.07.029
   PubMed Web of Science ®Google Scholar
• Kumar V, Sami N, Kashav T, et al. Protein aggregation and neurodegenerative diseases: from theory to therapy. Eur J Med Chem. 2016;124:1105–1120. doi: 10.1016/j.ejmech.2016.07.054
   PubMed Web of Science ®Google Scholar
• Peters OM, Ghasemi M, Brown RH. Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125(5):1767–1779. doi: 10.1172/JCI71601
   PubMed Web of Science ®Google Scholar
• Rossi S, Cozzolino M, Carri MT. Old versus new mechanisms in the pathogenesis of ALS. Brain Pathol. 2016;26(2):276–286. doi: 10.1111/bpa.12355
   PubMed Web of Science ®Google Scholar
• Ruegsegger C, Saxena S. Proteostasis impairment in ALS. Brain Res. 2016;1648(Pt B):571–579. doi: 10.1016/j.brainres.2016.03.032
   PubMed Web of Science ®Google Scholar
• Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197–206. doi: 10.1038/nature20413
   PubMed Web of Science ®Google Scholar
• Baskerville V, Rapuri S, Mehlhop E, et al. SUN1 facilitates CHMP7 nuclear influx and injury cascades in sporadic amyotrophic lateral sclerosis. Brain. 2023;147(1):109–121. doi: 10.1093/brain/awad291
   Web of Science ®Google Scholar
• Chou CC, Zhang Y, Umoh ME, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci. 2018;21(2):228–239. doi: 10.1038/s41593-017-0047-3
   PubMed Web of Science ®Google Scholar
• Cornelison GL, Levy SA, Jenson T, et al. Tau-induced nuclear envelope invagination causes a toxic accumulation of mRNA in Drosophila. Aging Cell. 2019;18(1):e12847. doi: 10.1111/acel.12847
   PubMed Web of Science ®Google Scholar
• Coyne AN, Baskerville V, Zaepfel BL, et al. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci Transl Med. 2021;13(604). 10.1126/scitranslmed.abe1923
   Web of Science ®Google Scholar
• Coyne AN, Zaepfel BL, Hayes L, et al. G(4)C(2) repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS/FTD. Neuron. 2020;107(6):1124–1140.e11. doi: 10.1016/j.neuron.2020.06.027
   PubMed Web of Science ®Google Scholar
• Eftekharzadeh B, Daigle JG, Kapinos LE, et al. Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease. Neuron. 2018;99(5):925–940.e7. doi: 10.1016/j.neuron.2018.07.039
   PubMed Web of Science ®Google Scholar
• Frost B, Bardai FH, Feany MB. Lamin dysfunction mediates neurodegeneration in Tauopathies. Curr Biol. 2016;26(1):129–136. doi: 10.1016/j.cub.2015.11.039
   PubMed Web of Science ®Google Scholar
• Grima JC, Daigle JG, Arbez N, et al. Mutant huntingtin disrupts the nuclear pore complex. Neuron. 2017;94(1):93–107.e6. doi: 10.1016/j.neuron.2017.03.023
   PubMed Web of Science ®Google Scholar
• Schöneberg J, Lee I-H, Iwasa JH, et al. Reverse-topology membrane scission by the ESCRT proteins. Nat Rev Mol Cell Biol. 2017;18(1):5–17. doi: 10.1038/nrm.2016.121
   PubMed Web of Science ®Google Scholar
• Babst M, Katzmann DJ, Snyder WB, et al. Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev Cell. 2002;3(2): 271–282. doi: 10.1016/S1534-5807(02)00219-8
   PubMed Web of Science ®Google Scholar
• Babst M, Katzmann DJ, Snyder WB, et al. Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Dev Cell. 2002;3(2): 283–289. DOI:10.1016/S1534-5807(02)00219-8
   PubMed Web of Science ®Google Scholar
• Katzmann DJ, Babst M, Emr SD. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell. 2001;106(2):145–155. doi: 10.1016/S0092-8674(01)00434-2
   PubMed Web of Science ®Google Scholar
• Ren X, Kloer DP, Kim YC, et al. Hybrid structural model of the complete human ESCRT-0 complex. Structure. 2009;17(3):406–416. doi: 10.1016/j.str.2009.01.012
   PubMed Web of Science ®Google Scholar
• Hirano S, Kawasaki M, Ura H, et al. Double-sided ubiquitin binding of hrs-UIM in endosomal protein sorting. Nat Struct Mol Biol. 2006;13(3):272–277. doi: 10.1038/nsmb1051
   PubMed Web of Science ®Google Scholar
• Mizuno E, Kawahata K, Kato M, et al. STAM proteins bind ubiquitinated proteins on the early endosome via the VHS domain and ubiquitin-interacting motif. Mol Biol Cell. 2003;14(9): 3675–3689. doi: 10.1091/mbc.e02-12-0823
   PubMed Web of Science ®Google Scholar
• Hurley JH, Hanson PI. Membrane budding and scission by the ESCRT machinery: it’s all in the neck. Nat Rev Mol Cell Biol. 2010;11(8):556–566. doi: 10.1038/nrm2937
   PubMed Web of Science ®Google Scholar
• Christ L, Raiborg C, Wenzel EM, et al. Cellular functions and molecular mechanisms of the ESCRT membrane-scission machinery. Trends Biochem Sci. 2017;42(1):42–56. doi: 10.1016/j.tibs.2016.08.016
   PubMed Web of Science ®Google Scholar
• Bajorek M, Schubert HL, McCullough J, et al. Structural basis for ESCRT-III protein autoinhibition. Nat Struct Mol Biol. 2009;16(7):754–762. doi: 10.1038/nsmb.1621
   PubMed Web of Science ®Google Scholar
• Lata S, Roessle M, Solomons J, et al. Structural basis for autoinhibition of ESCRT-III CHMP3. J Mol Biol. 2008;378(4):818–827. doi: 10.1016/j.jmb.2008.03.030
   PubMed Web of Science ®Google Scholar
• McCullough J, Clippinger AK, Talledge N, et al. Structure and membrane remodeling activity of ESCRT-III helical polymers. Science. 2015;350(6267):1548–1551. doi: 10.1126/science.aad8305
   PubMed Web of Science ®Google Scholar
• McMillan BJ, Tibbe C, Jeon H, et al. Electrostatic interactions between elongated monomers drive filamentation of drosophila shrub, a metazoan ESCRT-III protein. Cell Rep. 2016;16(5):1211–1217. doi: 10.1016/j.celrep.2016.06.093
   PubMed Web of Science ®Google Scholar
• Tang S, Henne WM, Borbat PP, et al. Structural basis for activation, assembly and membrane binding of ESCRT-III Snf7 filaments. Elife. 2015;4:4. doi: 10.7554/eLife.12548
   Web of Science ®Google Scholar
• Shim S, Kimpler LA, Hanson PI. Structure/function analysis of four core ESCRT-III proteins reveals common regulatory role for extreme C-terminal domain. Traffic. 2007;8(8):1068–1079.
   PubMed Web of Science ®Google Scholar
• Tang S, Buchkovich NJ, Henne WM, et al. ESCRT-III activation by parallel action of ESCRT-I/II and ESCRT-0/Bro1 during MVB biogenesis. Elife. 2016;5:5. doi: 10.7554/eLife.15507
   Web of Science ®Google Scholar
• Gu M, LaJoie D, Chen OS, et al., LEM2 recruits CHMP7 for ESCRT-mediated nuclear envelope closure in fission yeast and human cells. Proc natl acad sci USA, 2017. 114(11): p. E2166–e2175.
   Google Scholar
• Thaller DJ, Allegretti M, Borah S, et al. An ESCRT-LEM protein surveillance system is poised to directly monitor the nuclear envelope and nuclear transport system. Elife. 2019;8:8. doi: 10.7554/eLife.45284
   Web of Science ®Google Scholar
• von Appen A, LaJoie D, Johnson IE, et al. LEM2 phase separation promotes ESCRT-mediated nuclear envelope reformation. Nature. 2020;582(7810):115–118. doi: 10.1038/s41586-020-2232-x
   PubMed Web of Science ®Google Scholar
• Webster BM, Thaller DJ, Jäger J, et al. Chm7 and Heh1 collaborate to link nuclear pore complex quality control with nuclear envelope sealing. Embo J. 2016;35(22):2447–2467. doi: 10.15252/embj.201694574
   PubMed Web of Science ®Google Scholar
• Pfitzner AK, Mercier V, Jiang X, et al. An ESCRT-III polymerization sequence drives membrane deformation and fission. Cell. 2020;182(5):1140–1155.e18.
   PubMed Web of Science ®Google Scholar
• Ader NR, Chen L, Surovtsev IV, et al. An ESCRT grommet cooperates with a diffusion barrier to maintain nuclear integrity. Nat Cell Biol. 2023;25(10):1465–1477. doi: 10.1038/s41556-023-01235-4
   PubMed Web of Science ®Google Scholar
• Adell MA, Teis D. Assembly and disassembly of the ESCRT-III membrane scission complex. FEBS Lett. 2011;585(20):3191–3196. doi: 10.1016/j.febslet.2011.09.001
   PubMed Web of Science ®Google Scholar
• Adell MAY, Migliano SM, Upadhyayula S, et al. Recruitment dynamics of ESCRT-III and Vps4 to endosomes and implications for reverse membrane budding. Elife. 2017;6:6. doi: 10.7554/eLife.31652
   Web of Science ®Google Scholar
• Pfitzner AK, Moservon Filseck J, Roux A. Principles of membrane remodeling by dynamic ESCRT-III polymers. Trends Cell Biol. 2021;31(10):856–868.
   PubMed Web of Science ®Google Scholar
• Cada AK, Pavlin MR, Castillo JP, et al. Friction-driven membrane scission by the human ESCRT-III proteins CHMP1B and IST1. Proc Natl Acad Sci USA. 2022;119(29):e2204536119. doi: 10.1073/pnas.2204536119
   PubMed Web of Science ®Google Scholar
• Henne WM, Stenmark H, Emr SD. Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb Perspect Biol. 2013;5(9). doi: 10.1101/cshperspect.a016766
   PubMed Web of Science ®Google Scholar
• Wollert T, Wunder C, Lippincott-Schwartz J, et al. Membrane scission by the ESCRT-III complex. Nature. 2009;458(7235):172–177. doi: 10.1038/nature07836
   PubMed Web of Science ®Google Scholar
• Allison R, Lumb JH, Fassier C, et al. An ESCRT–spastin interaction promotes fission of recycling tubules from the endosome. J Cell Bio. 2013;202(3):527–543. doi: 10.1083/jcb.201211045
   PubMed Web of Science ®Google Scholar
• McMahon HT, Boucrot E. Membrane curvature at a glance. J Cell Sci. 2015;128(6):1065–1070. doi: 10.1242/jcs.114454
   PubMed Web of Science ®Google Scholar
• Caillat C, Macheboeuf P, Wu Y, et al. Asymmetric ring structure of Vps4 required for ESCRT-III disassembly. Nat Commun. 2015;6(1):8781. doi: 10.1038/ncomms9781
   PubMedGoogle Scholar
• Davies BA, Azmi IF, Payne J, et al. Coordination of substrate binding and ATP hydrolysis in Vps4-mediated ESCRT-III disassembly. Mol Biol Cell. 2010;21(19):3396–3408.
   PubMed Web of Science ®Google Scholar
• Maity S, Caillat C, Miguet N, et al. VPS4 triggers constriction and cleavage of ESCRT-III helical filaments. Sci Adv. 2019;5(4):eaau7198. doi: 10.1126/sciadv.aau7198
   PubMed Web of Science ®Google Scholar
• Stuchell-Brereton MD, Skalicky JJ, Kieffer C, et al. ESCRT-III recognition by VPS4 ATPases. Nature. 2007;449(7163):740–744. doi: 10.1038/nature06172
   PubMed Web of Science ®Google Scholar
• Yang B, Stjepanovic G, Shen Q, et al. Vps4 disassembles an ESCRT-III filament by global unfolding and processive translocation. Nat Struct Mol Biol. 2015;22(6):492–498. doi: 10.1038/nsmb.3015
   PubMed Web of Science ®Google Scholar
• Lata S, Schoehn G, Jain A, et al. Helical structures of ESCRT-III are disassembled by VPS4. Science. 2008;321(5894): 1354–1357. DOI:10.1126/science.1161070
   PubMed Web of Science ®Google Scholar
• Scott A, Gaspar J, Stuchell-Brereton MD, et al. Structure and ESCRT-III protein interactions of the MIT domain of human VPS4A. Proc Natl Acad Sci USA. 2005;102(39):13813–13818. doi: 10.1073/pnas.0502165102
   PubMed Web of Science ®Google Scholar
• Gatta AT, Olmos Y, Stoten CL, et al. CDK1 controls CHMP7-dependent nuclear envelope reformation. Elife. 2021;10:10. doi: 10.7554/eLife.59999
   Web of Science ®Google Scholar
• Maciejowski J, Hatch EM. Nuclear membrane rupture and its consequences. Annu Rev Cell Dev Biol. 2020;36(1):85–114. doi: 10.1146/annurev-cellbio-020520-120627
   PubMedGoogle Scholar
• Meinke P, Mattioli E, Haque F, et al. Muscular dystrophy-associated SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections and myonuclear organization. PLOS Genet. 2014;10(9):e1004605. doi: 10.1371/journal.pgen.1004605
   PubMed Web of Science ®Google Scholar
• Wang JY, Yu I-S, Huang C-C, et al. Sun1 deficiency leads to cerebellar ataxia in mice. dis Model mech. Dis Models Mech. 2015;8(8):957–967. doi: 10.1242/dmm.019240
   PubMed Web of Science ®Google Scholar
• Dutta S, Bhattacharyya M, Sengupta K. Changes in the nuclear envelope in Laminopathies. Adv Exp Med Biol. 2018;1112:31–38.
   PubMed Web of Science ®Google Scholar
• Kang SM, Yoon MH, Park BJ. Laminopathies; mutations on single gene and various human genetic diseases. BMB Rep. 2018;51(7):327–337. doi: 10.5483/BMBRep.2018.51.7.113
   PubMed Web of Science ®Google Scholar
• Stiekema M, van Zandvoort MAMJ, Ramaekers FCS, et al. Structural and mechanical aberrations of the nuclear lamina in disease. Cells. 2020;9(8):1884. doi: 10.3390/cells9081884
   PubMed Web of Science ®Google Scholar
• Worman HJ. Nuclear lamins and laminopathies. J Pathol. 2012;226(2):316–325. doi: 10.1002/path.2999
   PubMed Web of Science ®Google Scholar
• Robijns J, Houthaeve G, Braeckmans K, et al. Loss of nuclear envelope integrity in aging and disease. Int Rev Cell Mol Biol. 2018;336:205–222.
   PubMed Web of Science ®Google Scholar
• Andreu I, Granero-Moya I, Chahare NR, et al. Mechanical force application to the nucleus regulates nucleocytoplasmic transport. Nat Cell Biol. 2022;24(6):896–905. doi: 10.1038/s41556-022-00927-7
   PubMed Web of Science ®Google Scholar
• Enyedi B, Niethammer P. Nuclear membrane stretch and its role in mechanotransduction. Nucleus. 2017;8(2):156–161. doi: 10.1080/19491034.2016.1263411
   PubMed Web of Science ®Google Scholar
• Janota CS, Calero-Cuenca FJ, Gomes ER. The role of the cell nucleus in mechanotransduction. Curr Opin Cell Biol. 2020;63:204–211. doi: 10.1016/j.ceb.2020.03.001
   PubMed Web of Science ®Google Scholar
• Lusk CP, King MC. The nucleus: keeping it together by keeping it apart. Curr Opin Cell Biol. 2017;44:44–50. doi: 10.1016/j.ceb.2017.02.001
   PubMed Web of Science ®Google Scholar
• King MC, Lusk CP. A model for coordinating nuclear mechanics and membrane remodeling to support nuclear integrity. Curr Opin Cell Biol. 2016;41:9–17. doi: 10.1016/j.ceb.2016.03.009
   PubMed Web of Science ®Google Scholar
• Halfmann CT, Sears RM, Katiyar A, et al. Repair of nuclear ruptures requires barrier-to-autointegration factor. J Cell Bio. 2019;218(7):2136–2149. doi: 10.1083/jcb.201901116
   PubMed Web of Science ®Google Scholar
• Barger SR, Penfield L, Bahmanyar S. Nuclear envelope assembly relies on CHMP-7 in the absence of BAF-LEM-mediated hole closure. J Cell Sci. 2023;136(21). doi: 10.1242/jcs.261385
   PubMed Web of Science ®Google Scholar
• Wallis SS, Ventimiglia LN, Otigbah E, et al. The ESCRT machinery counteracts nesprin-2G-mediated mechanical forces during nuclear envelope repair. Dev Cell. 2021;56(23):3192–3202.e8. DOI:10.1016/j.devcel.2021.10.022
   PubMed Web of Science ®Google Scholar
• Penfield L, Shankar R, Szentgyörgyi E, et al. Regulated lipid synthesis and LEM2/CHMP7 jointly control nuclear envelope closure. J Cell Bio. 2020;219(5): doi: 10.1083/jcb.201908179
   PubMed Web of Science ®Google Scholar
• Thaller DJ, Tong D, Marklew CJ, et al. Direct binding of ESCRT protein Chm7 to phosphatidic acid-rich membranes at nuclear envelope herniations. J Cell Biol. 2021;220(3):074880.
   Web of Science ®Google Scholar
• Vietri M, Schultz SW, Bellanger A, et al. Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation. Nat Cell Biol. 2020;22(7):856–867. doi: 10.1038/s41556-020-0537-5
   PubMed Web of Science ®Google Scholar
• Ventimiglia LN, Cuesta-Geijo MA , Martinelli N, et al. CC2D1B coordinates ESCRT-III activity during the mitotic reformation of the nuclear envelope. Dev Cell. 2018;47(5):547–563.e6.
   PubMed Web of Science ®Google Scholar
• Capella M, Martín Caballero L, Pfander B, et al. ESCRT recruitment by the S. cerevisiae inner nuclear membrane protein Heh1 is regulated by Hub1-mediated alternative splicing. J Cell Sci. 2020;133(24):jcs250688.
   Google Scholar
• Frost B, Hemberg M, Lewis J, et al. Tau promotes neurodegeneration through global chromatin relaxation. Nat Neurosci. 2014;17(3):357–366. doi: 10.1038/nn.3639
   PubMed Web of Science ®Google Scholar
• Paonessa F, Evans LD, Solanki R, et al. Microtubules deform the nuclear membrane and disrupt nucleocytoplasmic transport in tau-mediated frontotemporal dementia. Cell Rep. 2019;26(3):582–593.e5. doi: 10.1016/j.celrep.2018.12.085
   PubMed Web of Science ®Google Scholar
• Prissette M, Fury W, Koss M, et al. Disruption of nuclear envelope integrity as a possible initiating event in tauopathies. Cell Rep. 2022;40(8):111249. doi: 10.1016/j.celrep.2022.111249
   PubMed Web of Science ®Google Scholar
• Giampetruzzi A, Danielson EW, Gumina V, et al. Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis. Nat Commun. 2019;10(1):3827. doi: 10.1038/s41467-019-11837-y
   PubMedGoogle Scholar
• Coyne AN, Rothstein JD. The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei. Acta Neuropathol Commun. 2021;9(1):127. doi: 10.1186/s40478-021-01228-0
   PubMed Web of Science ®Google Scholar
• Sontag EM, Morales-Polanco F, Chen J-H, et al. Nuclear and cytoplasmic spatial protein quality control is coordinated by nuclear–vacuolar junctions and perinuclear ESCRT. Nat Cell Biol. 2023;25(5):699–713. doi: 10.1038/s41556-023-01128-6
   PubMed Web of Science ®Google Scholar
• Toyama BH, Arrojo e Drigo R, Lev-Ram V, et al. Visualization of long-lived proteins reveals age mosaicism within nuclei of postmitotic cells. J Cell Bio. 2018;218(2):433–444. doi: 10.1083/jcb.201809123
   PubMed Web of Science ®Google Scholar
• Beck M, Hurt E. The nuclear pore complex: understanding its function through structural insight. Nat Rev Mol Cell Biol. 2017;18(2):73–89. doi: 10.1038/nrm.2016.147
   PubMed Web of Science ®Google Scholar
• Capelson M, Hetzer MW. The role of nuclear pores in gene regulation, development and disease. EMBO Rep. 2009;10(7):697–705. doi: 10.1038/embor.2009.147
   PubMed Web of Science ®Google Scholar
• D’Angelo MA. Nuclear pore complexes as hubs for Gene Regulation. Nucleus. 2018 Jan 1;9(1):142–148. doi: 10.1080/19491034.2017.1395542
   PubMed Web of Science ®Google Scholar
• Dickmanns A, Kehlenbach RH, Fahrenkrog B. Nuclear pore complexes and nucleocytoplasmic transport: from structure to function to disease. Int Rev Cell Mol Biol. 2015;320:171–233.
   PubMed Web of Science ®Google Scholar
• Fahrenkrog B, Koser J, Aebi U. The nuclear pore complex: a jack of all trades? Trends Biochem Sci. 2004;29(4):175–182. doi: 10.1016/j.tibs.2004.02.006
   PubMed Web of Science ®Google Scholar
• Hampoelz B, Andres-Pons A, Kastritis P, et al. Structure and assembly of the nuclear pore complex. Annu Rev Biophys. 2019;48(1):515–536. doi: 10.1146/annurev-biophys-052118-115308
   PubMedGoogle Scholar
• Ibarra A, Hetzer MW. Nuclear pore proteins and the control of genome functions. Genes Dev. 2015;29(4):337–349. doi: 10.1101/gad.256495.114
   PubMed Web of Science ®Google Scholar
• Kabachinski G, Schwartz TU. The nuclear pore complex–structure and function at a glance. J Cell Sci. 2015;128(3):423–429. doi: 10.1242/jcs.083246
   PubMed Web of Science ®Google Scholar
• Knockenhauer KE, Schwartz TU. The nuclear pore complex as a flexible and dynamic gate. Cell. 2016;164(6):1162–1171. doi: 10.1016/j.cell.2016.01.034
   PubMed Web of Science ®Google Scholar
• Lin DH, Hoelz A. The structure of the nuclear pore complex (an update). Annu Rev Biochem. 2019;88(1):725–783. doi: 10.1146/annurev-biochem-062917-011901
   PubMed Web of Science ®Google Scholar
• Pascual-Garcia P, Capelson M. Nuclear pores in genome architecture and enhancer function. Curr Opin Cell Biol. 2019;58:126–133. doi: 10.1016/j.ceb.2019.04.001
   PubMed Web of Science ®Google Scholar
• Raices M, D’Angelo MA. Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions. Nat Rev Mol Cell Biol. 2012;13(11):687–699. doi: 10.1038/nrm3461
   PubMed Web of Science ®Google Scholar
• Raices M, D’Angelo MA. Nuclear pore complexes and regulation of gene expression. Curr Opin Cell Biol. 2017;46:26–32. doi: 10.1016/j.ceb.2016.12.006
   PubMed Web of Science ®Google Scholar
• Strambio-De-Castillia C, Niepel M, Rout MP. The nuclear pore complex: bridging nuclear transport and gene regulation. Nat Rev Mol Cell Biol. 2010;11(7):490–501. doi: 10.1038/nrm2928
   PubMed Web of Science ®Google Scholar
• Antonin W, Ellenberg J, Dultz E. Nuclear pore complex assembly through the cell cycle: regulation and membrane organization. FEBS Lett. 2008;582(14):2004–2016. doi: 10.1016/j.febslet.2008.02.067
   PubMed Web of Science ®Google Scholar
• Bodoor K, Shaikh S, Salina D, et al. Sequential recruitment of NPC proteins to the nuclear periphery at the end of mitosis. J Cell Sci. 1999;112(Pt13):2253–2264. doi: 10.1242/jcs.112.13.2253
   PubMedGoogle Scholar
• Dultz E, Ellenberg J. Live imaging of single nuclear pores reveals unique assembly kinetics and mechanism in interphase. J Cell Bio. 2010;191(1):15–22. doi: 10.1083/jcb.201007076
   PubMed Web of Science ®Google Scholar
• Dultz E, Wojtynek M, Medalia O, et al. The nuclear pore complex: birth, life, and death of a cellular behemoth. Cells. 2022;11(9):1456. doi: 10.3390/cells11091456
   PubMed Web of Science ®Google Scholar
• Güttinger S, Laurell E, Kutay U. Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nat Rev Mol Cell Biol. 2009;10(3):178–191. doi: 10.1038/nrm2641
   PubMed Web of Science ®Google Scholar
• Hampoelz B, Mackmull MT, Machado P, et al. Pre-assembled nuclear pores insert into the nuclear Envelope during early development. Cell. 2016;166(3):664–678.
   PubMed Web of Science ®Google Scholar
• Hampoelz B, Schwarz A, Ronchi P, et al. Nuclear pores assemble from nucleoporin condensates during oogenesis. Cell. 2019;179(3):671–686.e17. doi: 10.1016/j.cell.2019.09.022
   PubMed Web of Science ®Google Scholar
• Otsuka S, Bui KH, Schorb M, et al. Nuclear pore assembly proceeds by an inside-out extrusion of the nuclear envelope. Elife. 2016;5:5. doi: 10.7554/eLife.19071
   Web of Science ®Google Scholar
• Otsuka S, Ellenberg J. Mechanisms of nuclear pore complex assembly – two different ways of building one molecular machine. FEBS Lett. 2018;592(4):475–488. doi: 10.1002/1873-3468.12905
   PubMed Web of Science ®Google Scholar
• Otsuka S, Tempkin JOB, Zhang W, et al. A quantitative map of nuclear pore assembly reveals two distinct mechanisms. Nature. 2023;613(7944):575–581. doi: 10.1038/s41586-022-05528-w
   PubMed Web of Science ®Google Scholar
• Weberruss M, Antonin W. Perforating the nuclear boundary – how nuclear pore complexes assemble. J Cell Sci. 2016;129(24):4439–4447. doi: 10.1242/jcs.194753
   PubMed Web of Science ®Google Scholar
• Jokhi V, Ashley J, Nunnari J, et al. Torsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear envelope. Cell Rep. 2013;3(4):988–995. doi: 10.1016/j.celrep.2013.03.015
   PubMed Web of Science ®Google Scholar
• Mettenleiter TC, Müller F, Granzow H, et al. The way out: what we know and do not know about herpesvirus nuclear egress. Cell Microbiol. 2013;15(2): 170–178. DOI:10.1111/cmi.12044
   PubMed Web of Science ®Google Scholar
• Speese SD, Ashley J, Jokhi V, et al. Nuclear envelope budding enables large ribonucleoprotein particle export during synaptic wnt signaling. Cell. 2012;149(4): 832–846. DOI:10.1016/j.cell.2012.03.032
   PubMed Web of Science ®Google Scholar
• Lee CW, Wilfling F, Ronchi P, et al. Selective autophagy degrades nuclear pore complexes. Nat Cell Biol. 2020;22(2):159–166. doi: 10.1038/s41556-019-0459-2
   PubMed Web of Science ®Google Scholar
• Tomioka Y, Kotani T, Kirisako H, et al. TORC1 inactivation stimulates autophagy of nucleoporin and nuclear pore complexes. J Cell Bio. 2020 Jul 6;219(7):e201910063. doi: 10.1083/jcb.201910063
   PubMed Web of Science ®Google Scholar
• Toyama BH, Savas J, Park S, et al. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell. 2013;154(5): 971–982. DOI:10.1016/j.cell.2013.07.037
   PubMed Web of Science ®Google Scholar
• Coyne AN, Rothstein JD. Nuclear pore complexes — a doorway to neural injury in neurodegeneration. Nat Rev Neurol. 2022;18(6):348–362. doi: 10.1038/s41582-022-00653-6
   PubMed Web of Science ®Google Scholar
• Cristi AC, Rapuri S, Coyne AN. Nuclear pore complex and nucleocytoplasmic transport disruption in neurodegeneration. FEBS Lett. 2023;597(20):2546–2566. doi: 10.1002/1873-3468.14729
   PubMed Web of Science ®Google Scholar
• D’Angelo MA, Raices M, Panowski SH, et al. Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell. 2009;136(2): 284–295. doi: 10.1016/j.cell.2008.11.037
   PubMed Web of Science ®Google Scholar
• Fallini C, Khalil B, Smith CL, et al. Traffic jam at the nuclear pore: all roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol Dis. 2020;140:104835. doi: 10.1016/j.nbd.2020.104835
   PubMed Web of Science ®Google Scholar
• Dubey SK, Maulding K, Sung H, et al. Nucleoporins are degraded via upregulation of ESCRT-III/Vps4 complex in drosophila models of C9-ALS/FTD. Cell Rep. 2022;40(12):111379. doi: 10.1016/j.celrep.2022.111379
   PubMed Web of Science ®Google Scholar
• Megat S, Mora N, Sanogo J, et al. Integrative genetic analysis illuminates ALS heritability and identifies risk genes. Nat Commun. 2023;14(1):342. doi: 10.1038/s41467-022-35724-1
   PubMed Web of Science ®Google Scholar
• Hurley JH, Emr SD. The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu Rev Biophys Biomol Struct. 2006;35(1):277–298. doi: 10.1146/annurev.biophys.35.040405.102126
   PubMedGoogle Scholar
• Scott CC, Vacca F, Gruenberg J. Endosome maturation, transport and functions. Semin Cell Dev Biol. 2014;31:2–10. doi: 10.1016/j.semcdb.2014.03.034
   PubMed Web of Science ®Google Scholar
• Zhang J, Jiang Z, Shi A. Rab GTPases: the principal players in crafting the regulatory landscape of endosomal trafficking. Comput Struct Biotechnol J. 2022;20:4464–4472. doi: 10.1016/j.csbj.2022.08.016
   PubMed Web of Science ®Google Scholar
• Ahmed I, Akram Z, Iqbal HMN, et al. The regulation of endosomal sorting complex required for transport and accessory proteins in multivesicular body sorting and enveloped viral budding – an overview. Int J Biol Macromol. 2019;127:1–11. doi: 10.1016/j.ijbiomac.2019.01.015
   PubMed Web of Science ®Google Scholar
• Katzmann DJ, Stefan CJ, Babst M, et al. Vps27 recruits ESCRT machinery to endosomes during MVB sorting. J Cell Bio. 2003;162(3):413–423. doi: 10.1083/jcb.200302136
   PubMed Web of Science ®Google Scholar
• Metcalf D, Isaacs AM. The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes. Biochem Soc Trans. 2010;38(6):1469–1473. doi: 10.1042/BST0381469
   PubMedGoogle Scholar
• Williams RL, Urbé S. The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol. 2007;8(5):355–368. doi: 10.1038/nrm2162
   PubMed Web of Science ®Google Scholar
• Hanson PI, Roth R, Lin Y, et al. Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. J Cell Bio. 2008;180(2):389–402. doi: 10.1083/jcb.200707031
   PubMed Web of Science ®Google Scholar
• Saksena S, Wahlman J, Teis D, et al. Functional reconstitution of ESCRT-III assembly and disassembly. Cell. 2009;136(1): 97–109. DOI:10.1016/j.cell.2008.11.013
   PubMed Web of Science ®Google Scholar
• Teis D, Saksena S, Judson BL, et al. ESCRT-II coordinates the assembly of ESCRT-III filaments for cargo sorting and multivesicular body vesicle formation. Embo J. 2010;29(5):871–883. doi: 10.1038/emboj.2009.408
   PubMed Web of Science ®Google Scholar
• Hurley JH. ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol. 2008;20(1):4–11. doi: 10.1016/j.ceb.2007.12.002
   PubMed Web of Science ®Google Scholar
• Liou W, Geuze HJ, Geelen MJH, et al. The autophagic and endocytic pathways converge at the nascent autophagic vacuoles. J Cell Bio. 1997;136(1):61–70. doi: 10.1083/jcb.136.1.61
   PubMed Web of Science ®Google Scholar
• Lucocq J, Walker D. Evidence for fusion between multilamellar endosomes and autophagosomes in HeLa cells. Eur J Cell Biol. 1997;72(4):307–313.
   PubMed Web of Science ®Google Scholar
• Lee JA, Beigneux A, Ahmad ST, et al. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol. 2007;17(18):1561–1567. doi: 10.1016/j.cub.2007.07.029
   PubMed Web of Science ®Google Scholar
• Filimonenko M, Stuffers S, Raiborg C, et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Bio. 2007;179(3):485–500. doi: 10.1083/jcb.200702115
   PubMed Web of Science ®Google Scholar
• Urwin H, Authier A, Nielsen JE, et al. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum Mol Genet. 2010;19(11): 2228–2238. doiI: 10.1093/hmg/ddq100
   PubMed Web of Science ®Google Scholar
• Shim JH, Xiao C, Hayden MS, et al. CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis. J Cell Bio. 2006;172(7):1045–1056. doi: 10.1083/jcb.200509041
   PubMed Web of Science ®Google Scholar
• Ghazi-Noori S, Froud KE, Mizielinska S, et al. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. brain. 2012;135(3):819–832. doi: 10.1093/brain/aws006
   Google Scholar
• Krasniak CS, Ahmad ST. The role of CHMP2B(Intron5) in autophagy and frontotemporal dementia. brain res, 2016. 1649(Pt B):151–157. 10.1016/j.brainres.2016.02.051
   Google Scholar
• Ugbode C, West RJH. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;147:105144. doi: 10.1016/j.nbd.2020.105144
   PubMed Web of Science ®Google Scholar
• Niekamp P, Scharte F, Sokoya T, et al. Ca(2+)-activated sphingomyelin scrambling and turnover mediate ESCRT-independent lysosomal repair. Nat Commun. 2022;13(1):1875. doi: 10.1038/s41467-022-29481-4
   PubMed Web of Science ®Google Scholar
• Radulovic M, Schink KO, Wenzel EM, et al. ESCRT-mediated lysosome repair precedes lysophagy and promotes cell survival. Embo J. 2018;37(21): doi: 10.15252/embj.201899753
   PubMed Web of Science ®Google Scholar
• Wang F, Gómez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic. 2018;19(12):918–931. doi: 10.1111/tra.12613
   PubMed Web of Science ®Google Scholar
• Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998;21(12):516–520. doi: 10.1016/S0166-2236(98)01276-4
   PubMed Web of Science ®Google Scholar
• Arai T, Hasegawa M, Nonoka T, et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology. 2010;30(2):170–181. doi: 10.1111/j.1440-1789.2009.01089.x
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Kwon YT. Protein quality control by molecular chaperones in neurodegeneration. Front Neurosci. 2017;11:185. doi: 10.3389/fnins.2017.00185
   PubMed Web of Science ®Google Scholar
• Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7). doi: 10.1101/cshperspect.a028035
   Web of Science ®Google Scholar
• Gotzl JK, Lang CM, Haass C, et al. Impaired protein degradation in FTLD and related disorders. Ageing Res Rev. 2016;32:122–139. doi: 10.1016/j.arr.2016.04.008
   PubMed Web of Science ®Google Scholar
• Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10(S7):S10–S17. doi: 10.1038/nm1066
   PubMedGoogle Scholar
• Tai HC, Schuman EM. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci. 2008;9(11):826–838. doi: 10.1038/nrn2499
   PubMed Web of Science ®Google Scholar
• Malik BR, Maddison DC, Smith GA, et al. Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Mol Brain. 2019;12(1):100. doi: 10.1186/s13041-019-0504-x
   PubMed Web of Science ®Google Scholar
• Giovedì S, Ravanelli MM, Parisi B, et al. Dysfunctional autophagy and endolysosomal system in neurodegenerative diseases: relevance and therapeutic options. Front Cell Neurosci. 2020;14:602116. doi: 10.3389/fncel.2020.602116
   PubMed Web of Science ®Google Scholar
• Wang G, Mao Z. Chaperone-mediated autophagy: roles in neurodegeneration. Transl Neurodegener. 2014;3(1):20. doi: 10.1186/2047-9158-3-20
   PubMedGoogle Scholar
• Wang YT, Lu JH. Chaperone-mediated autophagy in neurodegenerative diseases: molecular mechanisms and pharmacological opportunities. Cells. 2022;11(14):2250. doi: 10.3390/cells11142250
   PubMed Web of Science ®Google Scholar
• Zhang W, Xu C, Sun J, et al. Impairment of the autophagy–lysosomal pathway in Alzheimer’s diseases: pathogenic mechanisms and therapeutic potential. Acta Pharm Sin B. 2022;12(3):1019–1040. doi: 10.1016/j.apsb.2022.01.008
   PubMed Web of Science ®Google Scholar
• Benyair R, Panapakkam Giridharan SS, Rivero-Ríos P, et al. Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration. Autophagy Rep. 2023;2(1): doi: 10.1080/27694127.2023.2166722
   PubMedGoogle Scholar
• Chen JJ, Nathaniel DL, Raghavan P, et al. Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation. J Biol Chem. 2019;294(50):18952–18966. doi: 10.1074/jbc.RA119.009432
   PubMed Web of Science ®Google Scholar
• Feng Q, Luo Y, Zhang X-N, et al. Mapt/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration. Autophagy. 2020;16(4):641–658. doi: 10.1080/15548627.2019.1633862
   PubMed Web of Science ®Google Scholar
• Deng HX, Chen W, Hong S-T, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477(7363):211–215. doi: 10.1038/nature10353
   PubMed Web of Science ®Google Scholar
• Freischmidt A, Wieland T, Richter B, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18(5):631–636. doi: 10.1038/nn.4000
   PubMed Web of Science ®Google Scholar
• Johnson JO, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5): 857–864. doi: 10.1016/j.neuron.2010.11.036
   PubMed Web of Science ®Google Scholar
• Nishimura AL, Mitne-Neto M, Silva HCA, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004;75(5):822–831. doi: 10.1086/425287
   PubMed Web of Science ®Google Scholar
• Allegretti M, Zimmerli CE, Rantos V, et al. In-cell architecture of the nuclear pore and snapshots of its turnover. Nature. 2020;586(7831):796–800. doi: 10.1038/s41586-020-2670-5
   PubMed Web of Science ®Google Scholar
• Li Z, Nakatogawa H. Degradation of nuclear components via different autophagy pathways. Trends Cell Biol. 2022;32(7):574–584. doi: 10.1016/j.tcb.2021.12.008
   PubMed Web of Science ®Google Scholar
• Luo M, Zhao X, Song Y, et al. Nuclear autophagy: an evolutionarily conserved mechanism of nuclear degradation in the cytoplasm. Autophagy. 2016;12(11):1973–1983. doi: 10.1080/15548627.2016.1217381
   PubMed Web of Science ®Google Scholar
• Chandra S, Mannino PJ, Thaller DJ, et al. Atg39 selectively captures inner nuclear membrane into lumenal vesicles for delivery to the autophagosome. J Cell Bio. 2021;220(12): doi: 10.1083/jcb.202103030
   Web of Science ®Google Scholar
• Parkinson N, Ince PG, Smith MO, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology. 2006;67(6):1074–1077. doi: 10.1212/01.wnl.0000231510.89311.8b
   PubMed Web of Science ®Google Scholar
• Holm IE, Englund E, Mackenzie IRA, et al. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol. 2007;66(10):884–891. doi: 10.1097/nen.0b013e3181567f02
   PubMed Web of Science ®Google Scholar
• Deng X, Sun X, Yue W, et al. CHMP2B regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1. J Cell Bio. 2022;221(1): doi: 10.1083/jcb.202103033
   Web of Science ®Google Scholar
• Liu G, Coyne AN, Pei F, et al. Endocytosis regulates TDP-43 toxicity and turnover. Nat Commun. 2017;8(1):2092. doi: 10.1038/s41467-017-02017-x
   PubMedGoogle Scholar
• Lee SM, Asress S, Hales CM, et al. TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration. Brain Commun. 2019;1(1):fcz014. doi: 10.1093/braincomms/fcz014
   PubMedGoogle Scholar
• Nana AL, Sidhu M, Gaus SE, et al. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology. Acta Neuropathol. 2019;137(1):27–46. doi: 10.1007/s00401-018-1942-8
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Warlick C, Coyne AN. Highly variable molecular signatures of TDP-43 loss of function are associated with nuclear pore complex injury in a population study of sporadic ALS patient iPsns. bioRxiv. 2023;571299.
   Google Scholar
• Baughn MW, Melamed Z, López-Erauskin J, et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science. 2023;379(6637):1140–1149. doi: 10.1126/science.abq5622
   PubMed Web of Science ®Google Scholar
• Melamed Z, López-Erauskin J, Baughn MW, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22(2):180–190. doi: 10.1038/s41593-018-0293-z
   PubMed Web of Science ®Google Scholar
• Ma XR, Prudencio M, Koike Y, et al. TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A. Nature. 2022;603(7899):124–130. doi: 10.1038/s41586-022-04424-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Schmid B, Nikolaisen NK, et al. Patient iPSC-derived neurons for disease modeling of frontotemporal dementia with mutation in CHMP2B. Stem Cell Rep. 2017;8(3):648–658. doi: 10.1016/j.stemcr.2017.01.012
   PubMed Web of Science ®Google Scholar
• West RJH, Ugbode C, Fort-Aznar L, et al. Neuroprotective activity of ursodeoxycholic acid in CHMP2B(Intron5) models of frontotemporal dementia. Neurobiol Dis. 2020;144:105047. doi: 10.1016/j.nbd.2020.105047
   PubMed Web of Science ®Google Scholar
• Chen Y, Krishnan G, Parsi S, et al. The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias. Acta Neuropathol Commun. 2022;10(1):169. doi: 10.1186/s40478-022-01476-8
   PubMed Web of Science ®Google Scholar